Related Experiment Video

Updated: Aug 10, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress

T G Hofmann1, S P Hehner, S Bacher

  • 1German Cancer Research Center (DKFZ), Department of Immunochemistry, Heidelberg.

FEBS Letters
|January 19, 1999
PubMed

Insights

Glucocorticoids (GCs) impact gene expression, apoptosis, and NF-kappaB signaling. Potent GCs like betamethasone excel at inducing gene expression and apoptosis, while all GCs inhibit NF-kappaB activity.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Immunology

Background:

  • Glucocorticoids (GCs) are critical regulators of cellular functions.
  • GCs exert effects through glucocorticoid receptor (GR) binding, apoptosis induction, and cross-talk with transcription factors like NF-kappaB.

Purpose of the Study:

  • To systematically compare natural and synthetic steroid hormones for their efficacy in mediating GC functions.
  • To elucidate the mechanisms underlying GC action on gene expression, apoptosis, and NF-kappaB signaling.

Main Methods:

  • Systematic comparison of various natural and synthetic steroid hormones.
  • Assessment of GR-mediated gene expression and apoptosis induction.
  • Analysis of GC effects on NF-kappaB-mediated transactivation and IkappaB-alpha dynamics.

Main Results:

  • Betamethasone, triamcinolone, dexamethasone, and clobetasol were identified as potent inducers of gene expression and apoptosis.
  • All tested GCs, including RU486, effectively reduced NF-kappaB transactivation, indicating ligand-induced GR nuclear localization is sufficient for transrepression.
  • GC treatment impaired TNF-alpha-induced IkappaB-alpha degradation without affecting NF-kappaB DNA binding.

Conclusions:

  • Specific GCs demonstrate superior efficacy in gene induction and apoptosis.
  • GR nuclear localization is a key mechanism for GC-mediated transrepression of NF-kappaB.
  • GCs modulate inflammatory signaling pathways by interfering with IkappaB-alpha degradation.

More Related Videos

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...